106 related articles for article (PubMed ID: 2709239)
1. Effects of excipients on the crystallization of pharmaceutical compounds during lyophilization.
Korey DJ; Schwartz JB
J Parenter Sci Technol; 1989; 43(2):80-3. PubMed ID: 2709239
[TBL] [Abstract][Full Text] [Related]
2. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
[TBL] [Abstract][Full Text] [Related]
3. Rapid optimization of protein freeze-drying formulations using ultra scale-down and factorial design of experiment in microplates.
Grant Y; Matejtschuk P; Dalby PA
Biotechnol Bioeng; 2009 Dec; 104(5):957-64. PubMed ID: 19530082
[TBL] [Abstract][Full Text] [Related]
4. Distinct effects of sucrose and trehalose on protein stability during supercritical fluid drying and freeze-drying.
Jovanović N; Bouchard A; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
Eur J Pharm Sci; 2006 Mar; 27(4):336-45. PubMed ID: 16338123
[TBL] [Abstract][Full Text] [Related]
5. Effect of co-solutes and process variables on crystallinity and the crystal form of freeze-dried myo-inositol.
Izutsu KI; Kusano R; Arai R; Yoshida H; Ito M; Shibata H; Sugano K; Goda Y; Terada K
Int J Pharm; 2016 Jul; 509(1-2):368-374. PubMed ID: 27282535
[TBL] [Abstract][Full Text] [Related]
6. Effects of sodium tetraborate and boric acid on nonisothermal mannitol crystallization in frozen solutions and freeze-dried solids.
Izutsu K; Ocheda SO; Aoyagi N; Kojima S
Int J Pharm; 2004 Apr; 273(1-2):85-93. PubMed ID: 15010133
[TBL] [Abstract][Full Text] [Related]
7. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
8. Physico-chemical lyophilization behavior of mannitol, human serum albumin formulations.
Hawe A; Friess W
Eur J Pharm Sci; 2006 Jun; 28(3):224-32. PubMed ID: 16580820
[TBL] [Abstract][Full Text] [Related]
9. Crystallization and X-ray diffraction of spray-dried and freeze-dried amorphous lactose.
Haque MK; Roos YH
Carbohydr Res; 2005 Feb; 340(2):293-301. PubMed ID: 15639249
[TBL] [Abstract][Full Text] [Related]
10. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage.
Abdelwahed W; Degobert G; Fessi H
Eur J Pharm Biopharm; 2006 Jun; 63(2):87-94. PubMed ID: 16621490
[TBL] [Abstract][Full Text] [Related]
11. The improved dissolution and prevention of ampoule breakage attained by the introduction of pretreatment into the production process of the lyophilized formulation of recombinant human Interleukin-11 (rhIL-11).
Hirakura Y; Kojima S; Okada A; Yokohama S; Yokota S
Int J Pharm; 2004 Nov; 286(1-2):53-67. PubMed ID: 15501002
[TBL] [Abstract][Full Text] [Related]
12. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
Anhorn MG; Mahler HC; Langer K
Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
[TBL] [Abstract][Full Text] [Related]
13. Supercritical fluid drying of carbohydrates: selection of suitable excipients and process conditions.
Bouchard A; Jovanović N; Hofland GW; Jiskoot W; Mendes E; Crommelin DJ; Witkamp GJ
Eur J Pharm Biopharm; 2008 Mar; 68(3):781-94. PubMed ID: 17702554
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the stabilisation of freeze-dried lysozyme and the physical properties of the formulations.
Liao YH; Brown MB; Martin GP
Eur J Pharm Biopharm; 2004 Jul; 58(1):15-24. PubMed ID: 15207533
[TBL] [Abstract][Full Text] [Related]
15. Freeze-drying of proteins: some emerging concerns.
Roy I; Gupta MN
Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):165-77. PubMed ID: 15032737
[TBL] [Abstract][Full Text] [Related]
16. Bulk Freeze-Drying Milling: a Versatile Method of Developing Highly Porous Cushioning Excipients for Compacted Multiple-Unit Pellet Systems (MUPS).
Siow CRS; Heng PWS; Chan LW
AAPS PharmSciTech; 2018 Feb; 19(2):845-857. PubMed ID: 29019116
[TBL] [Abstract][Full Text] [Related]
17. Micro-mechanical properties of drying material bridges of pharmaceutical excipients.
Farber L; Tardos GI; Michaels JN
Int J Pharm; 2005 Dec; 306(1-2):41-55. PubMed ID: 16274947
[TBL] [Abstract][Full Text] [Related]
18. Excipient crystallinity and its protein-structure-stabilizing effect during freeze-drying.
Izutsu K; Kojima S
J Pharm Pharmacol; 2002 Aug; 54(8):1033-9. PubMed ID: 12195816
[TBL] [Abstract][Full Text] [Related]
19. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design.
Vandecruys R; Peeters J; Verreck G; Brewster ME
Int J Pharm; 2007 Sep; 342(1-2):168-75. PubMed ID: 17573214
[TBL] [Abstract][Full Text] [Related]
20. Arginine as an Excipient for Protein Freeze-Drying: A Mini Review.
Stärtzel P
J Pharm Sci; 2018 Apr; 107(4):960-967. PubMed ID: 29183741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
